Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 21 04:00PM ET
1.71
Dollar change
+0.09
Percentage change
5.56
%
Index- P/E- EPS (ttm)-3.64 Insider Own51.38% Shs Outstand5.18M Perf Week7.85%
Market Cap8.86M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.52M Perf Month0.59%
Income-13.40M PEG- EPS next Q- Inst Own0.85% Short Float0.15% Perf Quarter10.32%
Sales1.20M P/S7.38 EPS this Y- Inst Trans- Short Ratio0.54 Perf Half Y-10.47%
Book/sh4.22 P/B0.41 EPS next Y- ROA-69.74% Short Interest0.00M Perf Year-55.93%
Cash/sh0.09 P/C18.85 EPS next 5Y- ROE-60.24% 52W Range1.35 - 9.00 Perf YTD-30.16%
Dividend Est.- P/FCF- EPS past 5Y-26.55% ROI-60.80% 52W High-81.00% Beta-0.01
Dividend TTM- Quick Ratio1.32 Sales past 5Y40.77% Gross Margin-100.64% 52W Low26.67% ATR (14)0.19
Dividend Ex-Date- Current Ratio1.32 EPS Y/Y TTM-19.63% Oper. Margin-1299.91% RSI (14)50.48 Volatility10.66% 11.51%
Employees19 Debt/Eq0.03 Sales Y/Y TTM-16.18% Profit Margin-1116.97% Recom1.00 Target Price80.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q-169.81% Payout- Rel Volume0.38 Prev Close1.62
Sales Surprise- EPS Surprise- Sales Q/Q-18.22% EarningsDec 22 AMC Avg Volume7.04K Price1.71
SMA207.08% SMA50-10.14% SMA200-24.73% Trades Volume2,644 Change5.56%
Dec-22-23 04:30PM
Dec-21-23 04:30PM
Nov-16-23 11:00AM
Aug-10-23 02:57AM
Aug-05-23 02:53PM
08:00AM Loading…
Jun-22-23 08:00AM
Jun-09-23 04:30PM
May-05-23 04:31PM
May-01-23 08:00AM
06:10AM
Apr-28-23 09:44AM
Mar-27-23 07:00AM
Mar-17-23 08:15AM
Mar-03-23 07:30AM
07:30AM
07:30AM Loading…
Mar-02-23 07:30AM
Feb-10-23 04:30PM
Feb-06-23 10:08AM
Jan-23-23 06:49AM
Jan-20-23 08:00AM
Jan-04-23 09:00AM
Dec-22-22 08:00AM
Dec-16-22 08:00AM
Dec-09-22 07:00AM
Nov-25-22 08:30AM
08:00AM
Nov-18-22 05:30PM
Nov-08-22 06:00AM
Oct-07-22 03:40PM
Sep-30-22 07:42PM
08:00AM Loading…
Sep-23-22 08:00AM
Sep-15-22 11:58AM
08:07AM
07:00AM
Sep-02-22 06:45AM
Aug-25-22 08:31PM
Aug-19-22 08:30AM
Aug-11-22 09:45AM
May-17-22 08:13AM
May-09-22 11:41AM
May-02-22 08:00AM
Apr-29-22 04:00PM
Apr-25-22 09:30AM
Apr-22-22 08:00AM
Apr-06-22 07:00AM
Mar-22-22 05:58PM
Mar-17-22 07:00AM
Jan-25-22 10:06AM
08:21AM
07:45AM
Jan-20-22 08:47AM
08:00AM
Jan-18-22 08:00AM
Jan-11-22 04:56AM
Jan-10-22 08:00AM
08:00AM
08:00AM
Dec-03-21 08:00AM
Oct-19-21 08:00AM
Oct-15-21 08:00AM
Sep-15-21 09:26AM
08:00AM
08:00AM
Aug-03-21 03:01PM
Jul-15-21 02:03AM
Jul-12-21 08:59AM
08:00AM
Jul-09-21 08:00AM
Jun-22-21 04:00PM
Jun-21-21 08:30AM
May-26-21 08:00AM
May-24-21 12:03PM
11:57AM
08:00AM
May-13-21 07:00AM
May-06-21 07:00AM
Apr-23-21 11:35AM
Apr-22-21 09:04AM
07:00AM
Apr-19-21 07:00AM
Mar-31-21 07:00AM
Jan-20-21 07:32AM
06:00AM
Jan-16-21 01:23AM
Dec-21-20 06:00AM
Dec-10-20 08:00AM
Oct-16-20 08:00AM
Oct-02-20 04:05PM
Sep-29-20 09:00PM
06:00AM
Sep-08-20 03:00AM
02:00AM
Sep-02-20 08:00AM
Sep-01-20 02:00AM
02:00AM
02:00AM
Aug-31-20 06:05PM
Aug-26-20 03:00AM
02:00AM
Aug-20-20 02:00AM
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.